BELLUS Health Reports First Quarter 2023 Financial Results and Business Highlights Life Science Investing
Abbott Announces New Partnerships and Programs to Advance its Diversity in Clinical Trials Initiative Pharmaceutical Investing
Knight Therapeutics Inc. announces voting results from the Annual General Meeting Pharmaceutical Investing
Johnson & Johnson to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference Pharmaceutical Investing
CSE Bulletin: Suspensions - ADMT, ABRT, CFT, GAIA, IWIN, PKG, POLE, PRTI, RWB, CALM, RVR, VEJI Pharmaceutical Investing
Knight to Present at the 2023 RBC Capital Markets Global Healthcare Conference in New York City Pharmaceutical Investing
Gilead Strengthens Early Pipeline in Oncology and Inflammation Through the Acquisition of XinThera Life Science Investing
Health Canada Approves AbbVie's RINVOQ® for the Treatment of Adults with Active Non-Radiographic Axial Spondyloarthritis Life Science Investing
